USA: Syngenta seeks approval for GM rice to help kidney patients
US agrochemicals company Syngenta is seeking regulatory approval for a genetically modified rice strain it says will improve the diet of patients undergoing kidney dialysis. The rice strain has been engineered to remove a protein which triggers allergic reactions. It has been designed for the Asian market, where dialysis patients cannot eat the local staple of rice because they suffer intolerance to its high protein content.
Get full access to all content, just $1 for 30 days
A Message From The Editor
just-food gives you the widest food market coverage.
Paid just-food members have unlimited access to all our exclusive content - including 17 years of archives.
I am so confident you will love complete access to our content that today I can offer you 30 days access for $1.
It’s our best ever membership offer – just for you.
Dean Best, editor of just-food
- Why personalisation will take-off in US food
- US food next wave on display at Winter Fancy Food
- Comment: Meal kits in US - don't believe the hype
- Column: Kraft Heinz, Unilever and sustainability
- General Mills sales woes continue - analysis
- Unilever 'lining up spreads sale'
- UK own-label firm Park Cakes sold in MBO
- Immigration crackdown "risk" for US dairy industry
- BRF plant suspended amid bribery allegations
- Brazil giants JBS, BRF probed over alleged bribery